Peter L. Havens, MD
Titles Medical director, HIV, Children's Hospital of Wisconsin; professor, Pediatrics and Epidemiology, Medical College of Wisconsin.
Division Critical Care, Infectious Diseases
Research interests Infectious/immunological diseases
Study interests Adherence, care systems, clinical infectious diseases in children, drug kinetics, HIV treatment, perinatal prevention.
Education Medical degree, University of Missouri School of Medicine, Kansas City, 1980; residency: The Children's Hospital, Boston, 1981-1984; fellowship, Pediatric Infectious Diseases, The Children's Hospital, Boston, 1984-1987, and Anesthesia (Intensive Care), The Children's Hospital, Boston, 1985-1987.
Certifications General Pediatrics, 1987; Pediatric Critical Care, 1987, 1995 and 2001; Pediatric Infectious Diseases, 1995 and 2001.
Honors Most Outstanding Teacher Award, Pediatric House Staff, Medical College and Children's Hospital, Milwaukee, 1988, 1989, 2005; Edward J. Lennon Endowed Clinical Teaching Award, Medical College, 1993; E. Grey Diamond, MD, Take Wing Award, University of Missouri-Kansas City School of Medicine, 1995; Award for Innovation, Association for Care of Children's Health, honorable mention, with other members of the Wisconsin HIV Primary Care Support Network, 1997; Medical College Society of Teaching Scholars, 1997; Wisconsin Chapter, American Academy of Pediatrics, 2002 Pediatrician of the Year, 2002; "Clinician's Clinician," for clinical excellence, voted by the faculty of the Department of Pediatrics, Medical College, 2005; AIDS Resource Center of Wisconsin Leadership Award, 2007.
Representative publications
- Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes, M, Havens P, Purswami M, Guar AH, Chadwick EG and the Pediatric AIDS Clinical Trials Group P1030 Team. Early Archiving and Predominance of Non-nucleoside Reverse Transcriptase Inhibitor-resistant HIV-1 among Recently Infected Infants Born in the United States. Journal of Infectious Diseases. 2007; 195:1402-10.
- Franklin JA, Lim HJ, Havens PL. Longitudinal Academic and Social Progress of Children with Perinatally Acquired HIV. Journal of Clinical Psychology in Medical Settings. 2007; 14:335-343.
- Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani, RM, Liu NX, Muenz LR, Harris DR, Havens PL and the Adolescent Trials Network for HIV/AIDS Interventions. Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir/Ritonavir in Adolescents and Young Adults with HIV infection - study ATN056. Antimicrobial Agents and Chemotherapy. 2008; 52:631-37.
- Robbins BL, Capparelli EV, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, Havens PL for the PACTG 1038 Team. Pharmacokinetics of High-dose Lopinavir/Ritonavir With and Without Saquinavir or Non-nucleoside Reverse Transcriptase Inhibitors in HIV-infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors - study PACTG P1038. Antimicrobial Agents and Chemotherapy. 2008; 52:3276-3283.
- American Academy of Pediatrics Committee on Pediatric AIDS. Policy Statement. HIV Testing and Prophylaxis to Prevent Mother-to-Child Transmission in the United States. Pediatrics. 2008; 122:1127-34. Committee chair, lead author.
- Havens, PL, Mofenson LM, American Academy of Pediatrics Committee on Pediatric AIDS. Clinical Report: Evaluation and Management of the Infant Exposed to Human Immunodeficiency Virus Type 1 in the United States. Pediatrics. 123:175-187.
Grants
- Member, Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention since 2002.
Contact Children's Research Institute 8701 Watertown Plank Road Wauwatosa, WI 53226 Phone: (414) 337-7070 Fax: (414) 337-7093 E-mail: phavens@mcw.edu
|